Cannabis Stock News- Investing in Cannabis and Hemp Stocks

Monday, October 26, 2020

Investorideas.com - Cannabis Stock News: Nextleaf Solutions (CSE: OILS) (OTCQB: OILFF) Granted 50th Patent and Provides Commercial Update

Friday, October 23, 2020

New #Stocks to Watch at Investor Ideas – Biotech (NASDAQ: $AZYO), Sports (NASDAQ: $ASO), Cleantech (NASDAQ: $ARRY), CBD (NASDAQ: $JUPW)

New #Stocks to Watch at Investor Ideas – Biotech (NASDAQ: $AZYO), Sports (NASDAQ: $ASO), Cleantech (NASDAQ: $ARRY), CBD (NASDAQ: $JUPW)

Point Roberts WA, Delta BC, October 23, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch. Today’s stocks in Biotech, Sports, Cleantech, Cannabis, Agriculture, Real Estate and China-Asia have been added to our list of free stock directories in each sector.

Read this in full at https://www.investorideas.com/news/2020/main/10231Stocks.asp

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

All new companies added this week are October IPO’s.

The latest biotech companies are involved in biopharmaceuticals, medical devices and biotechnology medicines.

The newest sports companies are involved in live TV sports streaming and sporting goods while the latest cleantech company is solar-related and the newest cannabis company is looking at CBD therapies.

The newest agriculture company is involved with avocado production and distribution, the real estate company is focused on its commercial property REIT portfolio and the China-Asia company is in childhood edutainment.

New Stocks added to Biotech stocks directory:

AZIYO BIOLOGICS, INC. (NasdaqGS:AZYO) is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties.

Pulmonx Corp (NasdaqGS:LUNG) is a commercial-stage medical technology company focused on providing planning tools and treatments for obstructive lung disease. Our solution is comprised of the Zephyr® Valve, Chartis® Pulmonary Assessment System and StratX® Lung Analysis Platform, and is designed to address the need for a more effective, minimally invasive treatment option for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). Specifically, our solution provides bronchoscopic lung volume reduction without surgery and its associated risks. It is used to treat patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches.

C4 Therapeutics, Inc. (NasdaqGS:CCCC) is a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.

Shattuck Labs, Inc. (NasdaqGS:STTK) is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of cancer and autoimmune disease. Compounds derived from Shattuck’s ARC platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. The company’s lead wholly owned program, SL-172154 (SIRPα-Fc-CD40L), which is designed to block the CD47 immune checkpoint and simultaneously agonize the CD40 pathway, is being evaluated in a Phase 1 trial. A second compound, SL-279252 (PD1-Fc-OX40L), is being evaluated in a Phase 1 trial in collaboration with Takeda Pharmaceuticals. Additionally, the company is advancing a proprietary Gamma Delta T Cell Engager platform, GADLEN™, which is designed to bridge gamma delta T cells to tumor antigens for the treatment of cancer. Shattuck has offices in both Durham, North Carolina and Austin, Texas.

SPRUCE BIOSCIENCES, INC. (NasdaqGS:SPRB) is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years.

Kronos Bio, Inc. (NasdaqGS:KRON) is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription. The company has headquarters in San Mateo, Calif., and a research facility in Cambridge, Mass.

Oncorus, Inc. (NasdaqGS:ONCR) is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients. Using its two distinct proprietary platforms, the Company is developing a pipeline of intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors. Oncorus’ lead product candidate, ONCR-177, is an intratumorally administered viral immunotherapy based on its oncolytic HSV-1 platform, referred to as the oHSV Platform, which leverages the Herpes Simplex Virus type 1, or HSV-1, a virus which has been clinically proven to effectively treat certain cancers

Codiak BioSciences, Inc. (NasdaqGS:CDAK) is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need. By leveraging the biology of exosomes as natural intercellular transfer mechanisms, Codiak has developed its proprietary engEx Platform to expand upon the innate properties of exosomes to design, engineer and manufacture novel exosome therapeutic candidates. Codiak has utilized its engEx Platform to generate a deep pipeline of engineered exosomes aimed at treating a broad range of disease areas, spanning oncology, neuro-oncology, neurology, neuromuscular disease and infectious disease.

Immunome Inc. (NasdaqCM:IMNM) is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated and an initial focus on oncology and infectious diseases, including COVID-19. Immunome’s proprietary discovery platform identifies novel therapeutic antibodies and their targets by leveraging highly educated components of the immune system, memory B cells, from patients who have learned to fight off their disease

New Stocks added to Sports stocks directory:

Academy Sports & Outdoors, Inc. (NasdaqGS:ASO) is one of the leading full-line sporting goods and outdoor recreation retailers in the United States. Originally founded in 1938 as a family business in Texas, Academy has grown to 259 stores across 16 contiguous states, primarily in the southern United States. Academy's mission is to provide "Fun for All" and Academy fulfills this mission with a localized merchandising strategy and value proposition that strongly connects with a broad range of consumers. Academy's product assortment focuses on key categories of outdoor, apparel, footwear and sports & recreation through both leading national brands and a portfolio of 17 private label brands, which go well beyond traditional sporting goods and apparel offerings.

fuboTV Inc. (NYSE:FUBO) is the leading sports-first live TV streaming platform offering subscribers access to tens of thousands of live sporting events annually as well as leading news and entertainment content. fuboTV’s base package, fubo Standard, features a broad mix of 100+ channels, including 43 of the top 50 Nielsen-ranked networks across sports, news and entertainment (Primetime A18-49). Continually innovating to give subscribers a premium viewing experience they can’t find with cable TV, fuboTV is regularly first-to-market with new product features and was the first virtual MVPD to stream in 4K. fuboTV merged with FaceBank Group in April 2020 to create a leading digital entertainment company, combining fuboTV’s direct-to-consumer live TV streaming platform for cord-cutters with FaceBank’s technology-driven IP in sports, movies and live performances.

New Stocks added to Cleantech stocks directory:

ARRAY Technologies Inc. (NasdaqGS:ARRY) is one of the world’s largest manufacturers of ground-mounting systems used in solar energy projects. The Company’s principal product is an integrated system of steel supports, electric motors, gearboxes, electronic controllers and software, commonly referred to as a single-axis “tracker.” Trackers move solar panels throughout the day to maintain an optimal orientation to the sun, which significantly increases their energy production. Solar energy projects that use trackers generate up to 25% more energy and deliver a lower levelized cost of energy than projects that use conventional “fixed tilt” mounting systems. Array Technologies is headquartered in the United States with offices in Europe, Central America, and Australia.

New Stocks added to Cannabis stocks directory:

Jupiter Wellness, Inc. (NasdaqCM:JUPW) is a functional wellness and natural health products company. With a tireless devotion to quality, sourcing, and customer care, our goal is to harness the scientifically-backed health benefits of CBD like arthritis relief and muscle relaxation to help the population live a more fulfilling life through a variety of forthcoming products.

New Stocks added to Agriculture/Food stocks directory:

Mission Produce, Inc. (NasdaqGS:AVO) is a world leader in sourcing, producing and distributing fresh avocados, servicing retail, wholesale and foodservice customers in over 25 countries. The Company’s operations consist of four packing facilities in the United States, Mexico and Peru, 11 distribution and ripening centers across the U.S., Canada, China and the Netherlands, as well as three sales offices in the U.S., China and the Netherlands.

New Stocks added to Real Estate stocks directory:

Presidio Property Trust, Inc. (NasdaqGS:SQFT) is an internally managed, diversified REIT. Our commercial real estate portfolio consists of approximately 1.1 million square feet comprised of 15 properties: 10 office properties, one industrial property and four retail properties. Our commercial portfolio is located in Southern California, Colorado, and North Dakota, and we are currently considering new commercial property acquisitions in a variety of additional markets across the United States. Our commercial property tenant base is diversified, which helps limit our exposure to any single industry in which our tenants operate. Additionally, we own approximately 130 model home properties located in seven states, with the majority located in Texas and Florida. This geographical clustering of our real estate portfolio enables us to minimize operating costs and leverage efficiencies by managing a number of properties utilizing minimal overhead and staff.

New Stocks added to China-Asia stocks directory:

iHuman Inc. (NYSE:IH) is a leading childhood edutainment company in China that is committed to transforming learning into a fun journey for every child. Benefiting from a legacy that combines a strong educational foundation and decades of experience in childhood education with cutting edge technology and an outstanding reputation for original entertainment content, iHuman provides children with unique, interactive, and entertaining learning experiences. The Company's comprehensive suite of innovative and high-quality products and services caters to the educational needs of kids at school and at home, both online and offline, and covers diverse subjects, including Chinese learning, English, mathematics and critical thinking, literacy and reading, Chinese culture, STEM and other subjects. iHuman's line-up of highly effective edutainment products and services include interactive and self-directed learning apps, as well as learning materials and smart learning devices. With solid pedagogy, deep understanding of children's education and psychology, as well as advanced technology capabilities in gamification, AI/AR technologies, and big data analysis, iHuman believes it will continue to provide learning experiences that are both educational and fun for children in China and all over the world through its integrated suite of childhood edutainment products and services.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.

We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.

Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Thursday, October 22, 2020

Investorideas.com - Montana Supreme Court Quickly Rejects Frivolous Lawsuit Against Marijuana Ballot Initiatives

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 485: (TSXV: $DB.V) (OTCQB: $DBCCF), (CSE: $XCX.C) (TSXV: $NUMI.V)

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 485: (TSXV: $DB.V) (OTCQB: $DBCCF), (CSE: $XCX.C) (TSXV: $NUMI.V)

Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland

Delta, Kelowna, BC, October 22, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/102220-StocksToWatch.mp3

Read this in full at https://www.investorideas.com/news/2020/cannabis-potcasts/10221DB-DBCCF-XCX-NUMI.asp

Hear the investor ideas potcast on Spotify

Hear Investor ideas cannabis potcast on iTunes

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

In today’s podcast we look at a few public and private company announcements.

Decibel Cannabis Company Inc. (TSX-V:DB) (OTCQB:DBCCF), a premium cannabis producer and retailer, announced the launch of cannabis derivative products produced at its extraction facility, The Plant.

"Our product strategy is driven by our intimate knowledge of the end consumer through our Prairie Records retail stores," said Adam Coates, Chief Growth Officer of Decibel. "This position allows for insights such as identifying whitespace opportunities the current market is not fulfilling, and understanding key product attributes consumers are looking for in established formats. With these insights, we are launching black market quality concentrates, high potency, strain specific vapes and the CÜE line of fast acting 10mg THC shot style beverages."

Product Launch Highlights

● 10 Product Skus Launched: Achieved its first 57 product sku registrations in Western Canada and a supply agreement with the Ontario Cannabis Retail Corporation, with 10 skus currently available in cannabis retail stores across British Columbia, Alberta and Saskatchewan. The first shipments of products were delivered in late Q3.

● Blendcraft by Qwest Concentrates: Decibel's first derivative product launches under the Blendcraft by Qwest banner with 4 skus of Wax (crumble) and 4 skus of Shatter. These high potency, in demand concentrates compliment the rare cultivar, craft dried flower products the Company produces under the Qwest Family of Brands.

● General Admission Vapes: Decibel has launched its new brand, General Admission, with four strain specific vapes (Berry G 33, Tropic GSC, Lemon Ice and Tropic Thunder) in 0.45g and 0.95g cartridges, and 0.3g disposable formats. With high potency THC dominant and THC/CBD balanced formulations and a strong value-for-price ratio, first shipments of these products have been successful with re-orders from initial product shipments achieved within the first week of launch.

● CÜE Fast Acting Cannabis Shots: The Company has entered into a definitive agreement with Origin Scientific Inc., a private Canadian company, to manufacture and distribute CÜE fast acting cannabis shots. CÜE has developed an industry leading, clinically proven and patented nano encapsulation technology that has been formulated into a fast-acting cannabis infused shot style beverage. "CÜE Lemon Tea", a 59ml cannabis shot with 10mg of THC and 30mg of naturally occurring caffeine is expected to be the initial product offering, which the Company anticipates to be available for sale in November.

AMP German Cannabis Group Inc. (CSE: XCX) providing German patients with a wide range of pharmaceutical grade medical cannabis products, announced it will be adding Little Green Pharma Ltd. (ASX: LGP) cannabis oil medicines to its catalogue for sale in Germany beginning in November 2020 subject to obtaining a BtM-registration (narcotic drug licence) of these products on behalf of AMP.

AMP is looking forward to offering premium EU-GMP full plant extract cannabis oil medicines branded under the LGP Classic brand, produced by the same consistent strains. AMP wants to introduce the LGP brand to the German market by selling "LGP Classic 20:5 Oils" (THC dominant) and additional products in the near term once AMP has established the brand in the German market. Whereas LGP`s full plant extracts originate from the same cannabis plants, many other cannabis extracts are sourced from varying cannabis plants.

Little Green Pharma is licenced to cultivate and produce medical cannabis in Australia and has obtained the required licences and permits to export to Germany. Little Green Pharma has its own Therapeutic Goods Administration ("TGA") GMP licensed manufacturing facility in addition to a six-year, exclusive manufacturing agreement with a third-party TGA-GMP licensed contract manufacturer based in Western Australia. The TGA-GMP certification, granted by Australia's Department of Health, is recognized by EU regulatory authorities as meeting EU-GMP standards enabling LGP products to be sold in Germany.

Dr. Stefan Feuerstein, Director and President of AMP, said: "We had a lot of requests for medical cannabis oils during our recent sales trip through Germany, where we met with medium-sized distributors and large pharmacists that are specializing in medical cannabis. To meet this demand, we are introducing the premium LGP Classic brand as our first extract brand for the German market. We wanted our first extract in our product line to be a premium, full plant extract that our sales team can introduce along with our other medical cannabis flower products. We will be adding additional cannabis oils in the coming months to satisfy our customers' strong demand for this product line."

Ms. Fleta Solomon, Managing Director of Little Green Pharma, commented, "Our focus is on producing the highest quality cannabis medicines for Australia and other countries where medicinal cannabis has been legalized. We are proud to be the first Australian company to supply Germany, the leading medicinal cannabis market in Europe, and that AMP will be introducing the LGP Classic brand. We expect strong sales from AMP as they immediately launch and invest in introducing our LGP Classic 20:5 oil to the German market and additional LGP Classic products in the near term."

Numinus Wellness Inc. (TSXV: NUMI), a company creating an ecosystem of health solutions centred on developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies, announced that they have harvested the first legal flush of Psilocybe mushrooms in Canada by a public company under its Health Canada-issued Controlled Drugs and Substances Dealer's Licence. This news coincides with other recent developments by Numinus Bioscience, the Company's 7,000 square foot analytics and research laboratory, which is focused on handling various psychedelic substances and developing analytical methods and formulations for the evolving psychedelics space.

"The first harvest of legally grown Psilocybe mushrooms is a significant milestone for the whole industry" said Michael Tan, Chief Operating Officer. "Now, we can progress with research and development of standardized cultivation, extraction, and testing methods and exploring product formulations to support safe, evidence-based, accessible psychedelic-assisted psychotherapy, as well as build a sequenced spore library."

Dennis McKenna, renowned ethnopharmacologist, Co-founder of the Heffter Research Institute, Founder of the McKenna Academy of Natural Philosophy, and member of Numinus' General Advisory Council, adds, "While there is a place for synthetic psilocybin in clinical practice, well-characterized and standardized extracts of natural forms of psilocybin i.e., mushrooms, cultivated and processed under stringent quality control protocols, are the wave of the future as therapeutic psilocybin gains acceptance. Given a choice, many people would prefer the option to use natural psilocybin. Mushrooms have been used in traditional medicine for literally thousands of years, and hence, they are just that much closer to these ancient traditions. Natural mushroom extracts are also likely to be far more affordable compared to synthetic psilocybin, and that is an important consideration when it comes to ensuring accessibility to this medicine which can be so beneficial to many people. Cost should not be a barrier to access these medicines, and the use of mushroom extracts will help ensure those who need them most can benefit from psilocybin therapies."

Numinus Bioscience is establishing itself at the forefront of analytical testing for psychedelic substances, as a centre of excellence for psychedelic product research and development, and as an ancillary for psychedelic therapy clinical trials. Health Canada licences, scientific expertise, and state-of-the-art technologies facilitate ongoing innovation, while revenue from high-throughput contract cannabis testing is reinvested to further its psychedelic initiatives.

In addition to today's announcement, Numinus includes in its recent developments an amendment application to its Health Canada-issued Controlled Drugs and Substances Licence. The current licence permits testing, import and export, storage and distribution of MDMA, Psilocybin, Psilocin, DMT, and Mescaline as well as the undertaking of novel mycological research initiatives. The amendment will additionally permit the sale of Psilocybe mushroom fruiting bodies and extract for clinical research protocols and the development of standardized testing for additional psychedelic substances.

Numinus is also proud to announce the recent appointment of Sharan Sidhu, regulatory expert and policy advisor for restrictive high growth industries, as Science Officer and General Manager. Sidhu brings extensive experience as a hub between academia, industry, and governing directorates to align research objectives with regulatory compliance. She has been a key strategist for research roadmaps, core initiatives, the development of IP, and the development of compliance requirements including LIMS, GLP/GMP, GACP, and ISO Standards.

"Sharan's experience and leadership are already proving instrumental in establishing Numinus Bioscience as a centre of excellence and major industry player in the delivery of safe, evidence-based, accessible psychedelic-psychotherapy," said Payton Nyquvest, CEO, Founder, and Chairman. "We are honoured to have her join us on our mission."

Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

To hear more Investorideas.com podcasts visit:

https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com